OTSUKA PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.otsuka.co.jp
Confirmatory Study of OPC-12759 Ophthalmic Solution
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 209
- Registration Number
- NCT01660256
- Locations
- 🇯🇵
Kansai Region, Kansai Region, Japan
🇯🇵Kanto region, Kanto Region, Japan
🇯🇵Kyushu region, Kyushu Region, Japan
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT01634243
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients
- First Posted Date
- 2012-06-29
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 321
- Registration Number
- NCT01631825
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients
- First Posted Date
- 2012-06-29
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 130
- Registration Number
- NCT01631812
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
Phase 3
Completed
- Conditions
- Parkinson's Disease
- Interventions
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 420
- Registration Number
- NCT01628926
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 143
- Registration Number
- NCT01628965
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 174
- Registration Number
- NCT01628848
A Long-term, Extended Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
- First Posted Date
- 2012-06-12
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT01617460
A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
Phase 3
Completed
- Conditions
- Autistic Disorder
- Interventions
- First Posted Date
- 2012-06-12
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 92
- Registration Number
- NCT01617447
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome
- First Posted Date
- 2012-03-26
- Last Posted Date
- 2014-04-23
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 185
- Registration Number
- NCT01562743
© Copyright 2025. All Rights Reserved by MedPath